Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 18, 2025 17:56 ET | Source: Bragar Eagel & Squire

VALNEVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Valneva SE on Behalf of Valneva Stockholders and Encourages Investors to Contact the Firm

Valneva ADRs plunged after CDC probed IXCHIQ safety in Feb. 2025, then fell further in Aug. 2025 when FDA suspended the vaccine’s application.
September 11, 2025 17:16 ET | Source: Bragar Eagel & Squire

VALNEVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Valneva SE on Behalf of Valneva Stockholders and Encourages Investors to Contact the Firm

CDC, then FDA flagged safety issues with IXCHIQ; Valneva ADRs fell 13.6% in Feb. and another 19% in Aug. 2025 on suspension news.
September 04, 2025 17:33 ET | Source: Bragar Eagel & Squire

VALNEVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Valneva SE on Behalf of Valneva Stockholders and Encourages Investors to Contact the Firm

Valneva’s IXCHIQ vaccine faced CDC/FDA safety concerns; disclosures in 2025 triggered ADR declines of 13.6% and 19%, harming investors.